Blefarospasmo essencial e espasmo hemifacial: Características dos pacientes, tratamento com toxina botulínica A e revisão da literatura
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
27/05/2014
27/05/2014
01/01/2006
|
Resumo |
Purpose: To evaluate the characteristics of the essential blepharospasm and hemifacial spasm patients and the feasible treatment with botulinum toxin. A. Methods: Thirty-four essential blepharospasm or hemifacial spasm patients were evaluated according to gender, ocular complaint, time of disease, treatment outcome and complications. Results: Age median was 63 years and the mean was 61 years, with no difference regarding sex; 66.66% of the patients had hemifacial spasm and 33.33%, essential blepharospasm. Many patients complained of dry eye associated with involuntary spasm. Botulinum toxin A showed a positive outcome in 91.30% of the treated patients and complications observed after treatment were eyelid ptosis (8.33%) and buccal angle deviation (8.33%). Conclusion: Essential blepharospasm and hemifacial spasm occurred in the elderly, of both sexes. Treatment with botulinum toxin A was useful, with very low complication rates. |
Formato |
23-26 |
Identificador |
http://dx.doi.org/10.1590/S0004-27492006000100005 Arquivos Brasileiros de Oftalmologia, v. 69, n. 1, p. 23-26, 2006. 0004-2749 1678-2925 http://hdl.handle.net/11449/68714 10.1590/S0004-27492006000100005 S0004-27492006000100005 2-s2.0-33746359326 2-s2.0-33746359326.pdf |
Idioma(s) |
por |
Relação |
Arquivos Brasileiros de Oftalmologia |
Direitos |
openAccess |
Palavras-Chave | #Action potentials #Blepharospasm/drug therapy #Botulinum toxin type A/therapeutic use #Hemifacial spasm/drug therapy #Oculomotor muscles #botulinum toxin A #adult #blepharospasm #cheek mucosa #clinical article #clinical feature #controlled study #dry eye #feasibility study #female #gender #hemifacial spasm #human #male #ptosis #review #treatment outcome #Adult #Aged #Blepharospasm #Botulinum Toxin Type A #Female #Hemifacial Spasm #Humans #Male #Middle Aged #Neuromuscular Agents #Treatment Outcome |
Tipo |
info:eu-repo/semantics/article |